Biotest AG logo

BIO3 - Biotest AG News Story

€30 -0.1  -0.3%

Last Trade - 09/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.03bn
Enterprise Value £1.36bn
Revenue £420.2m
Position in Universe 387th / 1045

BRIEF-Biotest says Tiancheng to enter into domination agreement

Thu 8th February, 2018 5:58pm
Feb 8 (Reuters) - Biotest Ag  BIOG.DE : 
    * DGAP-ADHOC: BIOTEST AG: TIANCHENG INTENDS TO ENTER INTO A 
DOMINATION AND PROFIT AND LOSS TRANSFER AGREEMENT WITH BIOTEST 
AG 
    * SAYS TIANCHENG INTENDS TO ENTER INTO A DOMINATION AND 
PROFIT 
AND LOSS TRANSFER AGREEMENT WITH BIOTEST AG 
    * SAYS TIANCHENG HAS ASKED TO ENTER INTO NEGOTIATIONS 
    * SAYS EXPECTS THAT CASH COMPENSATION AND GUARANTEED 
DIVIDEND FOR 
MINORITY SHAREHOLDERS OF BIOTEST AG WILL BE DETERMINED IN 
ACCORDANCE WITH STATUTORY REQUIREMENTS AND ON BASIS OF A PENDING 
EVALUATION OF COMPANY 
    * SAYS INTENDED DOMINATION AND PROFIT AND LOSS TRANSFER 
AGREEMENT 
REQUIRES APPROVAL OF GENERAL SHAREHOLDERS' MEETING OF BIOTEST 
AG 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nEQ8Q1cGNa 
Further company coverage:  BIOG.DE  
 
 (Frankfurt newsroom) 
 ((+49 69 7565 1270; Reuters Messaging: 
frankfurt.newsroom@thomsonreuters.net))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.